Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

McMaster University

$110,000.00

Identification of novel causal blood biomarkers to predict micro- and macro-vascular complications of Type 2 diabetes

FY 2017-18

Summary
Diabetes is a growing chronic disease affecting 6 million Canadians, and impacts their life expectancy and quality. Men with diabetes live five years less, and women six years less than those without diabetes. Prolonged high blood glucose exposure favors the progressive development of vessel complications in small and large arteries, leading to disabilities, including blindness, kidney dialysis, nerve damage, limb amputation, stroke, and heart attack. Already representing 5% of healthcare spending, diabetes is a healthcare burden, for which health costs continue to rise at 2.5% annually. Despite the progress made in the availability of diabetes medications and the management of concurrent diseases, such as hypertension and high blood lipids, patients with diabetes continue to increasingly suffer from complications. Thus, the beneficial effects of diabetes medications on vessel complications remain a subject of debate. Our study aims to identify novel blood markers (i.e., biomarkers) that (1) predict the occurrence of small and large vessel complications of diabetes, including kidney and eyes diseases, nerve damage, heart attack and stroke; and that (2) directly cause T2D complications, such that they can be targets for preventive interventions. Our research will be performed using innovative and integrated genetic-biomarker analyses from large international databases for which we have access, and biological samples from 8K participants from a multiethnic randomized clinical trial (ORIGIN). The goal of our research is to improve life expectancy and quality in patients with diabetes. Indeed, our studies will provide the necessary evidence to guide diabetes management by facilitating the early identification of subjects at high risk of developing diabetes complications. Our studies will also inform on novel therapeutic treatment options to reduce complications and limit public health expenses.
Program
CIHR Fellowship
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
376461
Name
Pigeyre Marie
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Health Professional Awards - Fellowships
Projecttitle
Identification of novel causal blood biomarkers to predict micro- and macro-vascular complications of Type 2 diabetes
Programtype2
Fellowship Programs
Orgnameinp2
McMaster University
Cihramount2
$110,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Biomarkers; Genomics; Integrated Genomic-Biomarker Approach; Macrovascular Complications; Mendelian Randomization; Microvascular Complications; Personalized Medicine; Prevention; Risk Stratification; Type 2 Diabetes
Abstract
Diabetes is a growing chronic disease affecting 6 million Canadians, and impacts their life expectancy and quality. Men with diabetes live five years less, and women six years less than those without diabetes. Prolonged high blood glucose exposure favors the progressive development of vessel complications in small and large arteries, leading to disabilities, including blindness, kidney dialysis, nerve damage, limb amputation, stroke, and heart attack. Already representing 5% of healthcare spending, diabetes is a healthcare burden, for which health costs continue to rise at 2.5% annually. Despite the progress made in the availability of diabetes medications and the management of concurrent diseases, such as hypertension and high blood lipids, patients with diabetes continue to increasingly suffer from complications. Thus, the beneficial effects of diabetes medications on vessel complications remain a subject of debate. Our study aims to identify novel blood markers (i.e., biomarkers) that (1) predict the occurrence of small and large vessel complications of diabetes, including kidney and eyes diseases, nerve damage, heart attack and stroke; and that (2) directly cause T2D complications, such that they can be targets for preventive interventions. Our research will be performed using innovative and integrated genetic-biomarker analyses from large international databases for which we have access, and biological samples from 8K participants from a multiethnic randomized clinical trial (ORIGIN). The goal of our research is to improve life expectancy and quality in patients with diabetes. Indeed, our studies will provide the necessary evidence to guide diabetes management by facilitating the early identification of subjects at high risk of developing diabetes complications. Our studies will also inform on novel therapeutic treatment options to reduce complications and limit public health expenses.
Competitiondate
201711
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Pigeyre, Marie
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $110,000~ $0~
McMaster University - $110,000 Grant (2017-18) | Canada Spends